SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,728.16 -281.09
( -0.36%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

69,148.70 434.90
(0.63%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3864135

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

18.14

137.8

EPS(TTM)

Face Value()

Div & Yield %

4.77

1.39

Back

modern engineering & projects limited

Scan Projects standalone net profit declines 13.33% in the June 2026 quarter

Aug 14,2026

Net profit of Scan Projects declined 13.33% to Rs 0.13 crore in the quarter ended June 2026 as against Rs 0.15 crore during the previous quarter ended June 2025. Sales declined 20.30% to Rs 2.16 crore in the quarter ended June 2026 as against Rs 2.71 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2.16	2.71	-20
OPM %	4.63	5.54	-
PBDT	0.19	0.21	-10
PBT	0.18	0.20	-10
NP	0.13	0.15	-13

77,728.16 -281.09 ( -0.36%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

69,148.70 434.90 (0.63%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)